← Back to Search

Behavioral Intervention

Visual Feedback Reach Training for Ataxia

N/A
Recruiting
Led By Amy J Bastian, PhD, PT
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 22-80
Cerebellar damage from stroke, tumor or degeneration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed every study visit week 1 to week 12
Awards & highlights

Study Summary

This trial will test if reinforcement-based training can help people with ataxia improve their reach over time, compared to standard care.

Who is the study for?
This trial is for individuals aged 22-80 with cerebellar ataxia due to stroke, tumor, or degeneration. It's not suitable for those with extrapyramidal symptoms, vestibular loss, sensory neuropathy, significant pain or dementia (Mini-Mental State exam score > 22), vision loss affecting task performance, or damage to brain areas outside the cerebellum.Check my eligibility
What is being tested?
The study tests a reinforcement-based training method against standard practices over several weeks to improve reaching movements in people with ataxia. Participants will receive reach training that includes visual feedback.See study design
What are the potential side effects?
Since this intervention involves physical therapy techniques and not medication, side effects are minimal but may include muscle soreness or fatigue from the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 22 and 80 years old.
Select...
I have damage to my cerebellum due to stroke, tumor, or degeneration.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed every study visit week 1 to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed every study visit week 1 to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hand path distance during natural reaching to the trained target locations.
Secondary outcome measures
ARAT ( Action Research Arm Test)
ICARS (International Cooperative Ataxia Rating Scale)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard Practice TrainingExperimental Treatment1 Intervention
Reach training with visual feedback. During each training session, participants will first be familiarized with the task and then will reach from a home position to 4 virtual targets that are presented in the front of the participant and within the workspace where most natural arm movements are performed. During training the participant will reach a total of 400 times. For standard practice, participants will be able to see a cursor that represents the position of the hand at all times and try to make straight reaches to the targets. This type of feedback provided specific information about the location of the hand.
Group II: Reinforcement TrainingExperimental Treatment1 Intervention
Reach training with visual feedback. During each training session, participants will first be familiarized with the task and then will reach from a home position to 4 virtual targets that are presented in the front of the participant and within the workspace where most natural arm movements are performed. During training the participant will reach a total of 400 times. For reinforcement training, participants will not see their hand or a cursor, but instead participants will receive target-specific binary feedback after each reach (i.e. based on running average of last 10 reaches to that target). Binary feedback indicates only whether the reach was successful or unsuccessful and provides no specific information about the location of the hand.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,779 Total Patients Enrolled
1 Trials studying Cerebellar Ataxia
25 Patients Enrolled for Cerebellar Ataxia
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,918 Total Patients Enrolled
3 Trials studying Cerebellar Ataxia
155 Patients Enrolled for Cerebellar Ataxia
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,858 Total Patients Enrolled
2 Trials studying Cerebellar Ataxia
225 Patients Enrolled for Cerebellar Ataxia

Media Library

Reach training with visual feedback (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03879018 — N/A
Cerebellar Ataxia Research Study Groups: Standard Practice Training, Reinforcement Training
Cerebellar Ataxia Clinical Trial 2023: Reach training with visual feedback Highlights & Side Effects. Trial Name: NCT03879018 — N/A
Reach training with visual feedback (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03879018 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research actively seeking participants?

"Affirmative. According to the information on clinicaltrials.gov, this investigation is currently searching for 18 people from a single clinic and has been running since August 1st 2019 with its most recent update being July 6th 2022."

Answered by AI

Is this research program including elderly individuals aged 85 or older?

"This clinical trial seeks patients between the ages of 22 and 80. For those below 18 years old, there are 18 trials available; for elderly people above 65, 33 studies can be found."

Answered by AI

Do I qualify to participate in this trial?

"This trial is recruiting 18 individuals who suffer from hypermetria and are between 22-80 years old. The necessary qualifications for participation include having sustained cerebellar damage due to stroke, tumour or degenerative conditions."

Answered by AI

How many participants are being treated in this research endeavor?

"Affirmative. Evidence published clinicaltrials.gov confirms that this medical experiment, which was initially listed on August 1st 2019 is actively recruiting participants. 18 individuals are needed to be recruited from 1 site."

Answered by AI
~3 spots leftby Apr 2025